2022
DOI: 10.1016/j.nano.2022.102597
|View full text |Cite
|
Sign up to set email alerts
|

Polymer nanomedicines with enzymatically triggered activation: A comparative study of in vitro and in vivo anti-cancer efficacy related to the spacer structure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…Moreover, the nondegradable β-Ala spacer was employed in a stable P-PEP construct as the control system. Recently, the ValCit spacer was introduced as a suitable spacer for the controlled release of the cytostatics [ 30 ], thus it was also applied in this study. Since bacterial infection and biofilm formation may lower the pH in the infected site, a pH-responsive hydrazone bond was introduced as well into the polymer-AMP construct to investigate the benefits of pH-sensitive release and re-activation of the AMP ( Figure 4 A).…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, the nondegradable β-Ala spacer was employed in a stable P-PEP construct as the control system. Recently, the ValCit spacer was introduced as a suitable spacer for the controlled release of the cytostatics [ 30 ], thus it was also applied in this study. Since bacterial infection and biofilm formation may lower the pH in the infected site, a pH-responsive hydrazone bond was introduced as well into the polymer-AMP construct to investigate the benefits of pH-sensitive release and re-activation of the AMP ( Figure 4 A).…”
Section: Resultsmentioning
confidence: 99%